Home
>
National Drug Code (NDC)
>
FOSINOPRIL Na
FOSINOPRIL Na - 60505-2511-4 - (FOSINOPRIL Sodium)
Drug Information of FOSINOPRIL Na
| Product NDC: | 60505-2511 |
| Proprietary Name: | FOSINOPRIL Na |
| Non Proprietary Name: | FOSINOPRIL Sodium |
| Active Ingredient(s): | 20 mg/1 & nbsp; FOSINOPRIL Sodium |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of FOSINOPRIL Na
| Product NDC: | 60505-2511 |
| Labeler Name: | Apotex Corp. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076906 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20050518 |
Package Information of FOSINOPRIL Na
| Package NDC: | 60505-2511-4 |
| Package Description: | 1000 TABLET in 1 BOTTLE (60505-2511-4) |
NDC Information of FOSINOPRIL Na
| NDC Code | 60505-2511-4 |
| Proprietary Name | FOSINOPRIL Na |
| Package Description | 1000 TABLET in 1 BOTTLE (60505-2511-4) |
| Product NDC | 60505-2511 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | FOSINOPRIL Sodium |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20050518 |
| Marketing Category Name | ANDA |
| Labeler Name | Apotex Corp. |
| Substance Name | FOSINOPRIL SODIUM |
| Strength Number | 20 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |
